H.S. Ayoub
H.S. Ayoub
Stop FollowingH.S. Ayoub
View as an RSS Feed
View H.S. Ayoub's Articles BY TICKER:
ABBI,
ABT,
ACCP.OB,
ACOR,
ACTC.OB,
AGIX,
AGN,
ALGN,
ALNY,
AMGN,
ANIK,
ANOR,
ANX,
ARIA,
ARQL,
ASPV,
ASTM,
AUXL,
AVXL.OB,
AZN,
BAX,
BAYRY.PK,
BBH,
BCRX,
BDMS,
BIIB,
BIOV,
BIVN,
BJGP,
BLTI,
BMRN,
BMS,
BMY,
BNT,
BOL,
BRKR,
BRL,
BSC,
BSTE,
BSX,
BUF,
BVF,
CAH,
CARN.PK,
CAXG.OB,
CBLI,
CCEL.OB,
CELG,
CEPH,
CNIC,
CNU,
CORT,
CRXL,
CYTC,
CYTR,
DGX,
DNDN,
DRRX,
DVAX,
EMBX,
EPCT.PK,
ERIC,
FBT,
FMS,
GE,
GERN,
GNBT.OB,
GNTA.OB,
GOOG,
GPCB,
GSK,
HCTL,
HEPH,
HGSI,
HNAB,
HOLX,
HQH,
HQL,
HSIC,
HSKA,
IACI,
IBB,
IDMI,
ILMN,
IMA,
IMCL,
INSV.OB,
IOMI,
IOX,
IVGN,
JNJ,
KDUS.OB,
KOOL,
KOSP,
LIFC,
LLY,
LNCR,
MCU,
MDT,
MLNM,
MRK,
MYL,
NADX,
NBI,
NFLX,
NOVN,
NSTK,
NVAX,
NVD,
NVO,
NVS,
NWBO.OB,
ONXX,
OPK,
OPTN,
ORNI.OB,
OSIP,
OSIR,
OXGN,
PARD,
PBE,
PDCO,
PDLI,
PFE,
PG,
PGLA,
PLX,
POLXF,
PTIE,
PTIL,
PVCT.OB,
PXSL,
RBAK,
RGEN,
RHHBY.PK,
RITA,
RX,
SDIX,
SFD,
SGEN,
SIGA,
SIRI,
SIRO,
SLXA,
SMTS,
SNSS,
SNY,
SPPI,
STEM,
TGEN,
THLD,
THOR,
TKPHF.PK,
TNOX,
TRGT,
UTK,
VAS,
VIAC,
VION.OB,
VNDA,
VRTX,
VVUS,
VXGN.OB,
WCG,
WCRX,
WYE,
XBI,
XRAY,
YHOO,
ZLCS
- Cephalon’s New CLL Drug Should Please Patients and Investors
- U.S. No Longer Epicenter of the Financial World
- Anavex Life Sciences Takes Cues from FDA in Combating Major Diseases
- Allergan Drops Unnecessarily on FDA BOTOX Review
- IDM Pharma Jumps 234% After Major "Coincidence"
- Somanetics Jumps on Volume Spike
- Hepatitis C Developments Drag Biotechs Down
- GlaxoSmithKline Heads 2007 Most Ethical Pharmas List
- Big Pharma Couples with Biotech: Marriage Made in Hell?
- Aoxing Pharmaceutical's Anti-Opioid Addiction Drug Approved by China’s FDA
- Protalix Stock Collapses On Unexplained Pricing of New Shares
- Inverview With Jonathan Houssian, RxElite Founder: We're "A Significant Growth Investment"
- Adventrx Plummets 80% On Cancer Drug Trial Results
-
Interview: Pluristem Life Systems VP Dr. Prather
on Sun, Sep 16, 2007 • Comment!
- Dendreon Has Competition: Northwest BioTherapeutics Gains Cancer Vaccine Approval
- Dendreon: Media Spotlight Generates Hype and Hysteria
- Dendreon Jumps on New Cancer Vaccine Report
- Investment Opportunities In Healthcare: An Interview With Alan Brochstein
- Corcept Stock Continues To Rally On Weight Loss News
- Why Did Protalix's Stock Offering Announcement Boost Shares?
-
Are China's Recent Changes In Health Policy A Pre-Olympics Tactic?
on Thu, Jun 14, 2007 • Comment!
- Strategic Diagnostics Jumps on Volume Spike
- Vion Plunges 60 Percent Following Tuesday's Jump
- Tiny Biotech Vion Jumps on Strong Volume, No News
- GE Healthcare, Heads Up: Thermogenesis Would Make A Great Buy
- ArQule Could Gain Ahead of American Society of Clinical Oncology Meeting
- Biotech Buyout Frenzy Continues
- Bruker BioSciences Plunges On Market Over-Reaction
- Align Technology Blows Past Estimates
-
AlphaMD: An Investor's Link to the Medical World
on Wed, Apr 25, 2007 • Comment!
- Tiny Provectus Pharmaceuticals Jumps 15% on 6x Volume
- Oxigene Gains 7% on 10x Volume
